Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AFIB OTCMKTS:ECIA OTCMKTS:MAGAA NASDAQ:TTOO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFIBAcutus Medical$0.00-50.0%$0.00$0.00▼$0.01$3K6.085,306 shs25,336 shsECIAEncision$0.00$0.15$0.00▼$0.42N/A1.32645 shsN/AMAGAAMagna-Lab$0.01$0.01$0.11▼$2.00$1.38M7.513,117 shsN/ATTOOT2 Biosystems$0.00$0.00$0.00▼$0.16$8K8.219,658 shs1,089 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFIBAcutus Medical0.00%0.00%-90.00%-50.00%-99.05%ECIAEncision0.00%-99.90%-99.90%-99.87%-99.94%MAGAAMagna-Lab0.00%0.00%0.00%-19.23%-86.26%TTOOT2 Biosystems0.00%+100.00%-86.67%-81.82%-99.75%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFIBAcutus Medical$0.00-50.0%$0.00$0.00▼$0.01$3K6.085,306 shs25,336 shsECIAEncision$0.00$0.15$0.00▼$0.42N/A1.32645 shsN/AMAGAAMagna-Lab$0.01$0.01$0.11▼$2.00$1.38M7.513,117 shsN/ATTOOT2 Biosystems$0.00$0.00$0.00▼$0.16$8K8.219,658 shs1,089 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFIBAcutus Medical0.00%0.00%-90.00%-50.00%-99.05%ECIAEncision0.00%-99.90%-99.90%-99.87%-99.94%MAGAAMagna-Lab0.00%0.00%0.00%-19.23%-86.26%TTOOT2 Biosystems0.00%+100.00%-86.67%-81.82%-99.75%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFIBAcutus Medical 0.00N/AN/AN/AECIAEncision 0.00N/AN/AN/AMAGAAMagna-Lab 0.00N/AN/AN/ATTOOT2 Biosystems 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFIBAcutus Medical$7.16M0.00N/AN/A($0.03) per share0.00ECIAEncision$6.55M0.00N/AN/A$0.14 per share0.00MAGAAMagna-LabN/AN/AN/AN/A($1.52) per shareN/ATTOOT2 Biosystems$7.68M0.00N/AN/A($6.91) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFIBAcutus Medical-$81.66M-$0.11N/AN/AN/A-272.74%-311.64%-11.57%8/7/2026 (Estimated)ECIAEncision-$220K-$0.03N/AN/AN/A-6.05%-22.33%-9.70%N/AMAGAAMagna-Lab-$130K$0.180.05N/AN/AN/A-12.32%42,399.99%N/ATTOOT2 Biosystems-$50.08M-$3.89N/AN/AN/A-563.16%N/A-174.06%7/28/2026 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAFIBAcutus MedicalN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/AN/ATTOOT2 BiosystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFIBAcutus MedicalN/A1.851.57ECIAEncision0.092.280.91MAGAAMagna-LabN/AN/AN/ATTOOT2 BiosystemsN/A0.400.24Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFIBAcutus Medical56.91%ECIAEncision8.20%MAGAAMagna-LabN/ATTOOT2 Biosystems23.18%Insider OwnershipCompanyInsider OwnershipAFIBAcutus Medical5.21%ECIAEncision36.75%MAGAAMagna-Lab15.30%TTOOT2 Biosystems0.03%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAFIBAcutus Medical34029.91 million28.23 millionOptionableECIAEncision3016.88 million10.68 millionNot OptionableMAGAAMagna-Lab201.18 millionN/ANot OptionableTTOOT2 Biosystems18021.04 million21.04 millionNo DataECIA, MAGAA, TTOO, and AFIB HeadlinesRecent News About These CompaniesReviewing T2 Biosystems (NASDAQ:TTOO) & Dynatronics (NASDAQ:DYNT)May 29 at 4:46 AM | americanbankingnews.comT2 Biosystems (NASDAQ:TTOO) vs. Interpace Biosciences (OTCMKTS:IDXG) Head to Head AnalysisMay 23, 2026 | americanbankingnews.comT2 Biosystems Inc.May 19, 2026 | marketwatch.comT2 Biosystems to Wind Down OperationsFebruary 4, 2026 | 360dx.com3T2 Biosystems, Inc. Announces Intent to Complete Winding Down of OperationsFebruary 3, 2026 | finance.yahoo.comT2 Biosystems (NASDAQ:TTOO) versus Minerva Surgical (NASDAQ:UTRS) Head-To-Head ReviewJanuary 10, 2026 | defenseworld.netDIn Hot Water: Jasmine Crockett Faces Probe Over Conflicting Financial DisclosuresNovember 11, 2025 | dailysignal.comDT2 Biosystems Inc. (TTOO): 2025 Product Pipeline and Strategy Analysis ReportOctober 21, 2025 | finance.yahoo.comTTOO T2 Biosystems, Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comT2 Biosystems Inc. (TTOO) After Hours QuoteJune 10, 2025 | nasdaq.comDespite Promising Technology, Did Operational Cost Structure Take Down T2 Biosystems?March 5, 2025 | 360dx.com3T2 Biosystems initiates major layoffs, seeks asset saleFebruary 22, 2025 | uk.investing.comMedical diagnostics firm T2 Biosystems cuts ‘substantially all’ workersFebruary 18, 2025 | bizjournals.comT2 Biosystems to be delisted from NasdaqFebruary 11, 2025 | msn.comT2 Biosystems stock plunges to 52-week low of $0.22January 30, 2025 | msn.comT2 Biosystems Inc’s Stock Drama: Could This Be a Game-Changer for TTOO Investors?January 24, 2025 | bovnews.comBT2 Biosystems stock plunges to 52-week low of $0.25January 21, 2025 | msn.comT2 Biosystems amends loan terms, extends maturity dateJanuary 18, 2025 | msn.comT2 Biosystems reports preliminary Q4 revenue $2.3MJanuary 7, 2025 | markets.businessinsider.comT2 Biosystems Reports Preliminary Financial Results For Q4 And Full Year 2024January 7, 2025 | markets.businessinsider.comMedia Sentiment Over Time Top HeadlinesView All HeadlinesIs Costco Preparing Another Special Dividend This Year?By Dan Schmidt | May 8, 2026Nebius Breaks Out to All-Time Highs—Here's What's Driving It.By Ryan Hasson | May 5, 2026Airplane Maintenance Companies That Keep Flights Moving Are Ready to SoarBy Nathan Reiff | May 14, 2026Sherwin-Williams: The Boring Beauty Play on Housing RecoveryBy Chris Markoch | May 1, 2026Palomar’s High-Risk Insurance Strategy Is Paying Off BigBy Peter Frank | May 29, 2026ECIA, MAGAA, TTOO, and AFIB Company DescriptionsAcutus Medical NASDAQ:AFIB$0.0001 0.00 (-50.00%) As of 05/29/2026 12:22 PM EasternAcutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.Encision OTCMKTS:ECIA$0.0002 0.00 (0.00%) As of 05/29/2026Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.Magna-Lab OTCMKTS:MAGAA$0.0084 0.00 (0.00%) As of 05/29/2026Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. The company was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.T2 Biosystems NASDAQ:TTOO$0.0004 0.00 (0.00%) As of 05/29/2026 12:39 PM EasternT2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/25 - 05/29 Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17% Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem MongoDB's AI Advantage Is Starting to Show Up in Results Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys Dollar Tree Keeps Winning After Family Dollar Divorce Salesforce Stock Finds Support as AI Momentum Builds These 3 Software Stocks Are Buying Back Shares Hand Over Fist Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
